Status:
UNKNOWN
Promoting the Well Being of Caregivers Via Telehealth
Lead Sponsor:
Purdue University
Collaborating Sponsors:
University of Virginia
University of Oregon
Conditions:
Caregivers
Parents
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn which types of telehealth-based treatments best fit the needs of caregivers of people with rare neurogenetic conditions. The main questions it plans to answ...
Detailed Description
Project WellCAST (Supporting Wellbeing of Caregivers via Telehealth) is a multi-phase research study that aims to develop a scalable, personalized health approach for supporting caregivers of people w...
Eligibility Criteria
Inclusion
- Caregiver and legal guardian of child age 2-35 with neurogenetic condition
- Child's syndrome must (1) have an established genetic cause, (2) affect the brain, resulting in moderate to severe intellectual disability in the majority of patients
- Reside in US
- Fluent in English (spoken and written)
- Seeking support for caregiver mental health/well-being and/or caregiving needs
Exclusion
- Serious mental illness or active addiction that would be inadequately addressed through dosage of treatments
- Actively in treatment that would be redundant with those offered in the protocol
- Child's syndrome is not commonly associated with (1) life expectancy less than 35 years or (2) deterioration of previously gained skills.
- Additional treatment-specific inclusion criteria are embedded in the experimental algorithm that will be adjusted through Aim 1.
Key Trial Info
Start Date :
June 28 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 29 2025
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT05999448
Start Date
June 28 2023
End Date
December 29 2025
Last Update
August 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Purdue University
West Lafayette, Indiana, United States, 47907